Meeting Details
- Date: July 09, 2026
- Mode: Video Conferencing / Other Audio Visual Means
- Duration: 11:00 a.m. to 11:45 a.m. (45 minutes)
- Quorum: Requisite quorum was present
- Attendance: All Board Members were present
Resolutions Passed
All resolutions mentioned in the Notice of the 22nd AGM were passed through remote e-voting:
1. Adoption of Audited Financial Statements (Standalone and Consolidated) for the financial year ended March 31, 2026, along with Reports of the Board of Directors and Auditors
2. Declaration of final dividend of ₹10 per equity share (100%) for FY 2025-26 on shares with face value of ₹10 each
3. Re-appointment of Mr. Nirav Mehta (DIN: 01644041) as Director who retired by rotation
4. Appointment of M/s. Walker Chandiok & Co LLP, Chartered Accountants, as Statutory Auditors and fixation of their remuneration
5. Ratification of remuneration payable to Cost Auditors for FY 2026-27
6. Appointment of M/s. Dhara Patel, Company Secretary Firm as Secretarial Auditors
7. Approval of payment of commission to Non Executive Directors
8. Approval of payment of remuneration to Dr. Kirtikumar Mehta (DIN: 00385658), Non Executive Director and Chairman for FY 2026-27
9. Re-appointment of Dr. Kirtikumar Mehta as Non Executive Director and Chairman for a term of 5 years
Additional Information
- Voting results and Scrutinizer's Report will be disclosed separately as required under Regulation 44(3) of SEBI Listing Regulations
- The outcome is available on the company website at www.coronaremedies.com